Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Avogaro

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Journal of Endocrinological Investigation|February 19, 2005
Indexes of abdominal adiposity in patients with type 2 diabetesE Mannucci, S Spila Alegiani, M Monami, et al.
Diabetes, Obesity & Metabolism|May 29, 2014
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetesA Avogaro, A Dardano, S V de Kreutzenberg, et al.
Diabetes/Metabolism Reviews|May 1, 1989
Ketone body metabolism: a physiological and clinical overviewR Nosadini, A Avogaro, A Doria, et al.
Journal of Endocrinological Investigation|January 12, 2021
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist careM L Morieri, N Vitturi, A Avogaro, et al.
Alcoholism, Clinical and Experimental Research|June 1, 1986
Alcohol intake and withdrawal: effects on branched chain amino acids and alanineA Avogaro, M Cibin, T Croatto, et al.
Metabolism: Clinical and Experimental|November 1, 1982
The relationship between alanine and ketone body in vivoR Nosadini, A Mcculloch, S Del Prato, et al.
Diabetes|August 1, 1989
Stable-label intravenous glucose tolerance test minimal modelA Avogaro, J D Bristow, D M Bier, et al.
Nuclear Medicine Communications|April 6, 2004
Role of anti-granulocyte Fab' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical resultsD Rubello, D Casara, A Maran, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 1, 2016
A perspective on NETosis in diabetes and cardiometabolic disordersG P Fadini, L Menegazzo, V Scattolini, et al.
Diabetes, Obesity & Metabolism|December 17, 2011
The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patientsGian P Fadini, M Albiero, L Menegazzo, et al.
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Journal of Endocrinological Investigation|February 19, 2005
Indexes of abdominal adiposity in patients with type 2 diabetesE Mannucci, S Spila Alegiani, M Monami, et al.
Diabetes, Obesity & Metabolism|May 29, 2014
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetesA Avogaro, A Dardano, S V de Kreutzenberg, et al.
Diabetes/Metabolism Reviews|May 1, 1989
Ketone body metabolism: a physiological and clinical overviewR Nosadini, A Avogaro, A Doria, et al.
Journal of Endocrinological Investigation|January 12, 2021
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist careM L Morieri, N Vitturi, A Avogaro, et al.
Alcoholism, Clinical and Experimental Research|June 1, 1986
Alcohol intake and withdrawal: effects on branched chain amino acids and alanineA Avogaro, M Cibin, T Croatto, et al.
Metabolism: Clinical and Experimental|November 1, 1982
The relationship between alanine and ketone body in vivoR Nosadini, A Mcculloch, S Del Prato, et al.
Diabetes|August 1, 1989
Stable-label intravenous glucose tolerance test minimal modelA Avogaro, J D Bristow, D M Bier, et al.
Nuclear Medicine Communications|April 6, 2004
Role of anti-granulocyte Fab' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical resultsD Rubello, D Casara, A Maran, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 1, 2016
A perspective on NETosis in diabetes and cardiometabolic disordersG P Fadini, L Menegazzo, V Scattolini, et al.
Diabetes, Obesity & Metabolism|December 17, 2011
The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patientsGian P Fadini, M Albiero, L Menegazzo, et al.
Pageof 17